PMDA — authorised 25 March 2020
- Marketing authorisation holder: Nippon Shinyaku
- Status: approved
🇯🇵 Viltepso in Japan
PMDA authorised Viltepso on 25 March 2020
Marketing authorisations
PMDA
- Application: Viltepso
- Local brand name: Viltepso
- Status: approved
Viltepso in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in Japan
Frequently asked questions
Is Viltepso approved in Japan?
Yes. PMDA authorised it on 25 March 2020; PMDA has authorised it.
Who is the marketing authorisation holder for Viltepso in Japan?
Nippon Shinyaku holds the Japanese marketing authorisation.